AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frassinelli-Gunderson, E. P.
Right arrow Articles by Brown, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frassinelli-Gunderson, E. P.
Right arrow Articles by Brown, J. R.
Agricola
Right arrow Articles by Frassinelli-Gunderson, E. P.
Right arrow Articles by Brown, J. R.

American Journal of Clinical Nutrition, Vol 41, 703-712, Copyright © 1985 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Iron stores in users of oral contraceptive agents

EP Frassinelli-Gunderson, S Margen and JR Brown

A comparison of serum ferritin and other parameters of iron status was made between 46 women taking oral contraceptive agents (OCAs) for two or more years continuously and 71 women who never took OCAs. The mean serum ferritin level for the OCA users was 39.5 +/- 21.5 ng/ml and the control group mean level was 25.4 +/- 15.96 ng/ml, which is significantly different at p less than 0.001. Serum transferrin, serum iron, TIBC, MCH and MCHC levels were significantly greater for the OCA users group. Significantly lower RBC and hematocrit levels were found for OCA users while other parameters, hemoglobin, MCV and percent transferrin saturation, were not significantly different. No major differences in subject characteristics and dietary traits were evidenced, except a difference in reported menstrual cycle losses and a higher heme iron content in the diet of the OCA users.


This article has been cited by other articles:


Home page
 Clin. Chem.Home page
M. Haidari, E. Javadi, A. Sanati, M. Hajilooi, and J. Ghanbili
Association of Increased Ferritin with Premature Coronary Stenosis in Men
Clin. Chem., September 1, 2001; 47(9): 1666 - 1672.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
D H. Rushton, R. Dover, A. W Sainsbury, M. J Norris, J. J H Gilkes, and I. D Ramsay
Why should women have lower reference limits for haemoglobin and ferritin concentrations than men?
BMJ, June 2, 2001; 322(7298): 1355 - 1357.
[Full Text] [PDF]

Home page
 J. Nutr.Home page
J. L. Beard
Iron Biology in Immune Function, Muscle Metabolism and Neuronal Functioning
J. Nutr., February 1, 2001; 131(2): 568S - 580.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
B. de Valk and J. J. M. Marx
Iron, Atherosclerosis, and Ischemic Heart Disease
Arch Intern Med, July 26, 1999; 159(14): 1542 - 1548.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Helander, E. Vabo, K. Levin, and S. Borg
Intra- and interindividual variability of carbohydrate-deficient transferrin, {gamma}-glutamyltransferase, and mean corpuscular volume in teetotalers
Clin. Chem., October 1, 1998; 44(10): 2120 - 2125.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by The American Society for Nutrition